LicianPro

Mirum Pharmaceuticals, Inc. ·

MIRM 8-K 2026-09-28

Mirum Pharmaceuticals, Inc. (MIRM) 8-K dated 2026-09-28 — accession 0001759425-26-000049.

Mirum Pharmaceuticals, Inc. (MIRM) is a biotechnology company listed on NASDAQ.

Mirum Pharmaceuticals, Inc. filed a 8-K on 2026-09-28. Accession 0001759425-26-000049.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MIRM revenue for 2025-12-31 was $521.3M. Net income was -$23.4M. Revenue was up 54.7% from 2024-12-31 to 2025-12-31. MIRM currently screens at market cap $6.22B.

Not investment advice. The MIRM SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr